Showing results (241-250 of 287) with videos related to

Sort By:
Pageof 29
Digestive Diseases and Sciences|April 1, 2026
The Multiple Dimensions of Self-Management in Active Inflammatory Bowel Disease: A Qualitative Analysis of Patients' Daily Lived ExperiencesShirley Cohen-Mekelburg, Gal Hodish, Drew Ebner, et al.
Crohn'S & Colitis 360|September 9, 2022
Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter RegistryEdward L Barnes, Parakkal Deepak, Poonam Beniwal-Patel, et al.
Inflammatory Bowel Diseases|April 24, 2026
Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitisManjeet K Goyal, Priyata Dutta, Matthew C Choy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 22, 2026
New Diagnostic Criteria for Acute Severe Ulcerative Colitis in the Modern Treatment Era: A Modified Delphi Consensus by REFINED-ASUCTim Raine, Laurent Peyrin-Biroulet, Jakob Begun, et al.
The Lancet. Gastroenterology & Hepatology|May 10, 2025
Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension studyRemo Panaccione, Séverine Vermeire, Silvio Danese, et al.
Digestive Diseases and Sciences|June 24, 2026
Navigating Treatment Selection in Acute Severe Ulcerative Colitis: A Prospective Mixed Method Analysis of Factors Influencing Patient Decision-MakingReid Herran, Samuel Wilcox, Gal Hodish, et al.
Journal of Crohn'S & Colitis|March 2, 2016
European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's DiseaseFlorian Rieder, Giovanni Latella, Fernando Magro, et al.
Research Square|April 27, 2026
Navigating Treatment Selection in Acute Severe Ulcerative Colitis: A Prospective Mixed Method Analysis of Factors Influencing Patient Decision MakingReid Herran, Samuel Wilcox, Gal Hodish, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2021
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trialsDavid T Rubin, Iris Dotan, Aaron DuVall, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 1, 2016
Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic MiceHiroko Nagao-Kitamoto, Andrew B Shreiner, Merritt G Gillilland, et al.
Pageof 29